Genesis Therapeutics

Genesis Therapeutics

Biotechnology, Burlingame, California, 94080, United States, 11-50 Employees

genesistherapeutics.ai

  • facebook
  • LinkedIn

Who is GENESIS THERAPEUTICS

Genesis Therapeutics headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego is unifying AI and biotechnology to discover novel and breakthrough treatments for pa...

Read More

map
  • Burlingame, California, 94080, United States Headquarters: Burlingame, California, 94080, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • Evan Feinberg CEO:   Evan Feinberg

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from GENESIS THERAPEUTICS

Genesis Therapeutics Org Chart and Mapping

VP-Level
Employees

Wang Xu

Senior Director, Controller

Zach Kagin

Senior ML Research Engineer

Ken Leidal

Senior Machine Learning Research Engineer

Maruan Al-Shedivat

Director of Machine Learning

Shane Mitchel

Senior Research Associate - Biophysics

Pamela Kelley

Senior Director of Cmc Program Management

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Genesis Therapeutics

Answer: Genesis Therapeutics's headquarters are located at Burlingame, California, 94080, United States

Answer: Genesis Therapeutics's phone number is FALSE

Answer: Genesis Therapeutics's official website is https://genesistherapeutics.ai

Answer: Genesis Therapeutics's revenue is $5 Million to $10 Million

Answer: Genesis Therapeutics has 11-50 employees

Answer: Genesis Therapeutics is in Biotechnology

Answer: Genesis Therapeutics contact info: Phone number: FALSE Website: https://genesistherapeutics.ai

Answer: Genesis Therapeutics headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego is unifying AI and biotechnology to discover novel and breakthrough treatments for patients with severe and devastating conditions. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery. The GEMS platform integrates deep learning-based predictive models, molecular simulations, and molecular generative AI. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through multiple cycles of AI-enabled discovery and optimization. We have leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has two AI platform collaborations across a range of therapeutic areas: Eli Lilly (signed in 2022) and Genentech (signed in 2020). Genesis has raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. We are rapidly growing our team with a variety of openings on our machine learning, computational chemistry, and software teams (primarily located in the Bay Area) and our chemistry, biology, and clinical teams (primarily located in San Diego). To learn more about Genesis Therapeutics, or current employment opportunities, please visit our website.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access